Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key Findings

3.2.1 Top impacting factor
3.2.2 Top winning strategies
3.2.3 Top investment pockets

3.3 Value chain analysis
3.4 Porters five forces analysis

3.4.1 Low bargaining power of suppliers due to large number of suppliers and low switching cost
3.4.2 Moderate bargaining power of buyer due to high dem and, high product dependency and low switching cost
3.4.3 Moderate threat of substitutes due to less product differentiation and minimum ease of substitution
3.4.4 Moderate threat of substitutes due to increasing legal barriers, implementation of government policies and high dem and potential
3.4.5 Presence of numerous players, moderate product innovation and low switching cost increases the competition among rivalries

3.5 Drivers

3.5.1 Increased awareness of regulatory authorities concerning environment welfare
3.5.2 Replacement of in-vivo models by in-vitro models
3.5.3 Dem and of in-vitro methods for cancer diagnosis
3.5.4 Increase in global illicit drug abusers

3.6 RESTRAINTS

3.6.1 Reduction in adoption rate of in-vitro toxicity testing methods
3.6.2 Incapability of in vitro models to determine autoimmunity and immunostimulation

3.7 OPPORTUNITIES

3.7.1 Advancement in in-vitro technologies
3.7.2 Development of new in-vitro models

Chapter: 4 WORLD IVTT MARKET, BY TYPE

4.1 Overview
4.2 Absorption

4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 North America Absorption Market, ($Million), Growth (%) 2014-2022
4.2.5 Europe Absorption Market, ($Million), Growth (%) 2014-2022
4.2.6 Asia-pacific Absorption Market, ($Million), Growth (%) 2014-2022
4.2.7 LAMEA Absorption Market, ($Million), Growth (%) 2014-2022

4.3 Toxic substances

4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast
4.3.4 North America Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.3.5 Europe Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.3.6 Asia Pacific Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.3.7 LAMEA Toxic Substances Market, ($Million), Growth (%) 2014-2022

4.4 Dose

4.4.1 Key Market Trends
4.4.2 Key Growth Factors and Opportunities
4.4.3 Market Size and Forecast
4.4.4 North America Dose Market, ($Million), Growth (%) 2014-2022
4.4.5 Europe Dose Market, ($Million), Growth (%) 2014-2022
4.4.6 Asia Pacific Dose Market, ($Million), Growth (%) 2014-2022
4.4.7 LAMEA Dose Market, ($Million), Growth (%) 2014-2022

Chapter: 5 WORLD IVTT MARKET, BY END USER

5.1 Overview
5.2 Cosmetics and Household products

5.2.1 Key Market Trends
5.2.2 Key Growth Factors and Opportunities
5.2.3 Market Size and Forecast
5.2.4 North America Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.2.5 Europe Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.2.6 Asia Pacific Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.2.7 LAMEA Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022

5.3 Pharmaceutical industry

5.3.1 Key Market Trends
5.3.2 Key Growth Factors and Opportunities
5.3.3 Market Size and Forecast
5.3.4 North America Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.3.5 Europe Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.3.6 Asia Pacific Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.3.7 LAMEA Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022

5.4 Food industry

5.4.1 Key Market Trends
5.4.2 Key Growth Factors and Opportunities
5.4.3 Market Size and Forecast
5.4.4 North America Food Industry Market, ($Million), Growth (%) 2014-2022
5.4.5 Europe Food Industry Market, ($Million), Growth (%) 2014-2022
5.4.6 Asia-pacific Food Industry Market, ($Million), Growth (%) 2014-2022
5.4.7 LAMEA Food Industry Market, ($Million), Growth (%) 2014-2022

5.5 Chemical industry

5.5.1 Key Market Trends
5.5.2 Key Growth Factors and Opportunities
5.5.3 Market Size and Forecast
5.5.4 North America Chemical Industry Market, ($Million), Growth (%) 2014-2022
5.5.5 Europe Chemical Industry Market, ($Million), Growth (%) 2014-2022
5.5.6 Asia Pacific Chemical Industry Market, ($Million), Growth (%) 2014-2022
5.5.7 LAMEA Chemical Industry Market, ($Million), Growth (%) 2014-2022

Chapter: 6 WORLD IVTT MARKET BY GEOGRAPHY

6.1 Overview
6.2 North America

6.2.1 Key Market Trends
6.2.2 Key Growth Factors and Opportunities
6.2.3 Market Size and Forecast

6.3 Europe

6.3.1 Key Market Trends
6.3.2 Key Growth Factors and Opportunities
6.3.3 Market Size and Forecast

6.4 Asia-Pacific

6.4.1 Key Market Trends
6.4.2 Key Growth Factors and Opportunities
6.4.3 Market Size and Forecast

6.5 LAMEA

6.5.1 Key Market Trends
6.5.2 Key Growth Factors and Opportunities
6.5.3 Market Size and Forecast

Chapter: 7 COMPANY PROFILES

7.1 Agilent Technologies, Inc.

7.1.1 Company Snapshot
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategies & development

7.2 BioReliance, Inc.

7.2.1 Company Snapshot
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategies & development

7.3 Alere, Inc.

7.3.1 Company Snapshot
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategies & development

7.4 Charles River Laboratories International, Inc.

7.4.1 Company Snapshot
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategies & development

7.5 General Electric Company

7.5.1 Company Snapshot
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategies & development

7.6 Covance, Inc.

7.6.1 Company Snapshot
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategies & development

7.7 Catalent, Inc.

7.7.1 Company Snapshot
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategies & development

7.8 Eurofins Scientific

7.8.1 Company Snapshot
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategies & development

7.9 Bio-Rad Laboratories, Inc.

7.9.1 Company Snapshot
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategies & development

7.10 Thermo Fisher Scientific, Inc.

7.10.1 Company Snapshot
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategies & development